List of relevant, established and potential thrombophilic factors.
| 1 . | 2 . | 3 . |
|---|---|---|
| Column 1: factors of therapeutic and/or prognostic relevance; column 2: established risk factors with possible therapeutic and prognostic relevance for the individual patient; column 3: potential thrombophilic factors. Their therapeutic and prognostic relevance for the individual patient is doubtful. Laboratory tests for HIT type 2 and ADAMTS13 are only indicated when additional data suggest their involvement (see text). | ||
| Antithrombin | APC resistance (FV Leiden) | PAI-1 polymorphism |
| Protein C | Prothrombin G20210A | Plasminogen |
| Protein S | Lipoprotein (a) | Heparin-cofactor II |
| Antiphospholipid-Ab | Dysfibrinogenemia | FIX |
| Homocysteine | FVIII | FXI |
| HIT Type 2 | D-Dimer | FXIII |
| ADAMTS13 | VWF | |
| 1 . | 2 . | 3 . |
|---|---|---|
| Column 1: factors of therapeutic and/or prognostic relevance; column 2: established risk factors with possible therapeutic and prognostic relevance for the individual patient; column 3: potential thrombophilic factors. Their therapeutic and prognostic relevance for the individual patient is doubtful. Laboratory tests for HIT type 2 and ADAMTS13 are only indicated when additional data suggest their involvement (see text). | ||
| Antithrombin | APC resistance (FV Leiden) | PAI-1 polymorphism |
| Protein C | Prothrombin G20210A | Plasminogen |
| Protein S | Lipoprotein (a) | Heparin-cofactor II |
| Antiphospholipid-Ab | Dysfibrinogenemia | FIX |
| Homocysteine | FVIII | FXI |
| HIT Type 2 | D-Dimer | FXIII |
| ADAMTS13 | VWF | |